in this study 523 previously untreated patients with acute myelocytic leukemia were randomly allocated to induction therapy with daunorubicin 60 mg/m2 daily x 3 , cytosine arabinoside and thioguanine 100 mg/m2 each every 12 hours until marrow hypoplasia was achieved , or a 5-day course of the three drugs with daunorubicin 100 mg/m2 given on dav 1 and cytosine arabinoside plus thioguanine each given at a dose of 100 mg/m2 every 12 hours for five days .
C0039902
thioguanine
C0280589
cytosine arabinoside